세포배양 배지 시장 : 제품 유형, 용도, 최종 사용자별 - 세계 예측(2024-2032년)

Cell Culture Media Market size is projected to expand at 12.8% CAGR from 2024 to 2032. The rising demand for biopharmaceuticals, such as vaccines and monoclonal antibodies is necessitating the use of high-quality cell culture media in production processes. Technological developments, including the innovations in 3D cell cultures and stem cell research are driving the need for advanced media formulations.

The increasing research on chronic diseases, particularly cancer is also fueling the demand for cell culture media. As per data from the National Cancer Institute, in 2024, around 2,001,140 new cases of cancer will be diagnosed in the U.S. The expanding fields of regenerative medicine and tissue engineering is increasing the funding from government and private sectors for cell-based research, driving the industry growth.

The overall market is segregated into product type, application, end-user, and region.

Based on product type, the cell culture media market from the specialty media segment is estimated to rise at significant rate between 2024 and 2032, due to the increasing demand for personalized medicine, advancements in regenerative medicine, and stem cell research. Specialized formulations are essential for precise cellular environments as well as supporting the development of targeted therapies and complex cell culture techniques. The rising investments in biopharmaceutical R&D and the growing need for high-quality, reproducible results are driving the segment growth.

Cell culture media industry from the diagnostics application segment will grow at notable rate from 2024 to 2032, led by the expanding research in disease diagnostics and personalized medicine. Cell culture media is serving a crucial role in culturing patient-derived cells for diagnostic testing, biomarker discovery, and drug sensitivity assays. Moreover, the advancements in molecular diagnostics and the growing prevalence of chronic diseases are spurring the demand for accurate and reliable cell culture media formulations tailored to diagnostic applications.

Regionally, the Asia Pacific cell culture media market is anticipated to depict robust growth through 2032, owing to the expansion of the biopharmaceutical sector, particularly in countries like China and India. There have been rising investments in healthcare infrastructure and research facilities. The increasing adoption of advanced cell culture technologies, and growing awareness about personalized medicine is accelerating the product deployment. The launch of favorable government initiatives and collaborations with international biotech companies are also driving the regional market progression.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases
    • 3.2.1.2 Advancement in cell culture media technology
    • 3.2.1.3 Increasing demand for serum and animal component-free media
    • 3.2.1.4 Growing demand for regenerative medicine
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of cell biology products
    • 3.2.2.2 Stringent regulatory challenges
• 3.3 Growth potential analysis
• 3.4 Emerging technology landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company positioning matrix
• 4.4 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Serum-free media
  • 5.2.1 CHO media
  • 5.2.2 HEK 293 media
  • 5.2.3 BHK media
  • 5.2.4 VERO cell media
  • 5.2.5 Insect cell media
  • 5.2.6 Immune cell media
  • 5.2.7 Other serum-free media
• 5.3 Specialty media
• 5.4 Chemically defined media
• 5.5 Stem cell culture media
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Biopharmaceutical production
  • 6.2.1 Monoclonal antibodies
  • 6.2.2 Vaccine production
  • 6.2.3 Other biopharmaceutical productions
• 6.3 Diagnostics
• 6.4 Drug screening and development
• 6.5 Tissue engineering and regenerative medicine
• 6.6 Research purpose
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical and biotechnology companies
• 7.3 Hospital and diagnostic laboratories
• 7.4 Research and academic institutes
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021- 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 ACROBiosystems
• 9.2 Corning Incorporation
• 9.3 Danaher Corporation
• 9.4 FUJIFILM Irvine Scientific
• 9.5 Lonza Group
• 9.6 Merck KGaA
• 9.7 Miltenyi Biotech
• 9.8 Nuvonis
• 9.9 Sartorius AG
• 9.10 ScienCell Research Laboratories
• 9.11 Thermo Fisher Scientific Inc.